218 related articles for article (PubMed ID: 20725832)
21. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer.
Shen L; Qian Y; Wu W; Weng T; Wang FXC; Hong B; Wu Z; Wang Q; Sang Y; Zhang H; Zhou X; Yao H
Hum Pathol; 2017 Aug; 66():79-85. PubMed ID: 28600225
[TBL] [Abstract][Full Text] [Related]
22. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.
Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J
Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786
[TBL] [Abstract][Full Text] [Related]
23. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration.
Zhao LW; Li C; Zhang RL; Xue HG; Zhang FX; Zhang F; Gai XD
Acta Histochem; 2014 Sep; 116(7):1163-8. PubMed ID: 25053455
[TBL] [Abstract][Full Text] [Related]
24. The significance of immune-regulatory molecule B7-H4 in small cell lung cancer.
Zhang X; Song S; Zhang F; Cai L; Xie W
Ann Palliat Med; 2020 Jul; 9(4):1953-1957. PubMed ID: 32692215
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of B7-H4 is associated with infiltrating immune cells and poor prognosis in metastatic colorectal cancer.
Ding S; Lv X; Liu Z; Zhan S; Xu Y; Zhang X; Liu C; Cao L
Int Immunopharmacol; 2021 Jan; 90():107144. PubMed ID: 33187907
[TBL] [Abstract][Full Text] [Related]
26. Expression of B7-H4 in endometrial cancer and its impact on patients' prognosis.
Gorzelnik K; Wasaznik-Jedras A; Wicherek L; Szubert S
Ginekol Pol; 2024; 95(4):252-258. PubMed ID: 37873922
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases.
Qian Y; Sang Y; Wang FX; Hong B; Wang Q; Zhou X; Weng T; Wu Z; Zheng M; Zhang H; Yao H
Oncotarget; 2016 Nov; 7(44):72242-72249. PubMed ID: 27750217
[TBL] [Abstract][Full Text] [Related]
28. Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.
Fukuda T; Kamai T; Masuda A; Nukui A; Abe H; Arai K; Yoshida K
Cancer Med; 2016 Aug; 5(8):1810-20. PubMed ID: 27292320
[TBL] [Abstract][Full Text] [Related]
29. T-cell infiltration and expressions of T lymphocyte co-inhibitory B7-H1 and B7-H4 molecules among colorectal cancer patients in northeast China's Heilongjiang province.
Liang M; Li J; Wang D; Li S; Sun Y; Sun T; Zhang J; Chen X; Li Q; Sun S
Tumour Biol; 2014 Jan; 35(1):55-60. PubMed ID: 23873101
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer.
Huang H; Li C; Ren G
Gene; 2017 Aug; 623():24-28. PubMed ID: 28412458
[TBL] [Abstract][Full Text] [Related]
31. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
[TBL] [Abstract][Full Text] [Related]
32. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance.
Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S
Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032
[TBL] [Abstract][Full Text] [Related]
33. Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis.
Guo L; Liu Z; Zhang Y; Quan Q; Huang L; Xu Y; Cao L; Zhang X
Medicine (Baltimore); 2019 Feb; 98(8):e14663. PubMed ID: 30813210
[TBL] [Abstract][Full Text] [Related]
34. Circulating B7-H4 in serum predicts prognosis in patients with hepatocellular carcinoma.
Zhang SA; Wu ZX; Zhang X; Zeng ZY; Li DL
Genet Mol Res; 2015 Oct; 14(4):13041-8. PubMed ID: 26505457
[TBL] [Abstract][Full Text] [Related]
35. Expression of B7-H4 in blood of patients with gastric cancer predicts tumor progression and prognosis.
Arigami T; Uenosono Y; Hirata M; Hagihara T; Yanagita S; Ishigami S; Natsugoe S
J Surg Oncol; 2010 Dec; 102(7):748-52. PubMed ID: 20872810
[TBL] [Abstract][Full Text] [Related]
36. B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma.
Wu L; Deng WW; Yu GT; Mao L; Bu LL; Ma SR; Liu B; Zhang WF; Sun ZJ
Cancer Immunol Immunother; 2016 Sep; 65(9):1035-45. PubMed ID: 27383830
[TBL] [Abstract][Full Text] [Related]
37. B7-H4 is a potential prognostic biomarker of prostate cancer.
Li H; Piao L; Liu S; Cui Y; Xuan Y
Exp Mol Pathol; 2020 Jun; 114():104406. PubMed ID: 32088189
[TBL] [Abstract][Full Text] [Related]
38. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
[TBL] [Abstract][Full Text] [Related]
39. [Preparation of anti-B7-H4 monoclonal antibody to investigate B7-H4 expression in pancreatic cancer].
Hong B; Qian Y; Yao HP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 42(5):511-6. PubMed ID: 24167131
[TBL] [Abstract][Full Text] [Related]
40. B7-H4 promotes tumor growth and metastatic progression in lung cancer by impacting cell proliferation and survival.
Zhang X; Cai L; Zhang G; Shen Y; Huang J
Oncotarget; 2017 Mar; 8(12):18861-18871. PubMed ID: 28061481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]